相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
Kari R. Fischer et al.
NATURE (2015)
The aryl hydrocarbon receptor (AhR) mediates resistance to apoptosis induced in breast cancer cells
Kanae Bekki et al.
PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY (2015)
A Flexible Reporter System for Direct Observation and Isolation of Cancer Stem Cells
Binwu Tang et al.
STEM CELL REPORTS (2015)
The Ah receptor in stem cell cycling, regulation, and quiescence
Thomas A. Gasiewicz et al.
BONE MARROW NICHE, STEM CELLS, AND LEUKEMIA: IMPACT OF DRUGS, CHEMICALS, AND THE ENVIRONMENT (2014)
Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog
Anurag N. Paranjape et al.
BMC CANCER (2014)
The Cancer Stem Cell Marker Aldehyde Dehydrogenase Is Required to Maintain a Drug-Tolerant Tumor Cell Subpopulation
Debasish Raha et al.
CANCER RESEARCH (2014)
Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma
Mohammad Mahdi Forghanifard et al.
MEDICAL ONCOLOGY (2014)
Depletion of the Aryl Hydrocarbon Receptor in MDA-MB-231 Human Breast Cancer Cells Altered the Expression of Genes in Key Regulatory Pathways of Cancer
Gennifer Goode et al.
PLOS ONE (2014)
Pluripotency factors and Polycomb Group proteins repress aryl hydrocarbon receptor expression in murine embryonic stem cells
Chia-I Ko et al.
STEM CELL RESEARCH (2014)
Loss of Aryl Hydrocarbon Receptor Promotes Gene Changes Associated with Premature Hematopoietic Stem Cell Exhaustion and Development of a Myeloproliferative Disorder in Aging Mice
Kameshwar P. Singh et al.
STEM CELLS AND DEVELOPMENT (2014)
TCDD dysregulation of 13 AHR-target genes in rat liver
John D. Watson et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2014)
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Iain A. Murray et al.
NATURE REVIEWS CANCER (2014)
In Silico Identification of an Aryl Hydrocarbon Receptor Antagonist with Biological Activity In Vitro and In Vivo
Ashley J. Parks et al.
MOLECULAR PHARMACOLOGY (2014)
Isolation and characterization of human breast cancer cells with SOX2 promoter activity
Shanshan Liang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
The aryl hydrocarbon receptor directs hematopoietic progenitor cell expansion and differentiation
Brenden W. Smith et al.
BLOOD (2013)
HER2 overexpression-mediated inflammatory signaling enhances mammosphere formation through up-regulation of aryl hydrocarbon receptor transcription
Shuai Zhao et al.
CANCER LETTERS (2013)
Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells
Ming Qiu et al.
CANCER LETTERS (2013)
Breast Cancer Stem Cells: A Novel Therapeutic Target
Sudeshna Gangopadhyay et al.
CLINICAL BREAST CANCER (2013)
Disruption of Aryl Hydrocarbon Receptor Homeostatic Levels during Embryonic Stem Cell Differentiation Alters Expression of Homeobox Transcription Factors that Control Cardiomyogenesis
Qin Wang et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2013)
Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line
Gennifer D. Goode et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Role of the Aryl Hydrocarbon Receptor in Carcinogenesis and Potential as a Drug Target
Stephen Safe et al.
TOXICOLOGICAL SCIENCES (2013)
Inhibition of aldehyde dehydrogenase (ALDH) activity reduces chemotherapy and radiation resistance of stem-like ALDHhiCD44+ human breast cancer cells
Alysha K. Croker et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling
A. Dubrovska et al.
BRITISH JOURNAL OF CANCER (2012)
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Jeffrey A. Magee et al.
CANCER CELL (2012)
Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells
Shuai Zhao et al.
CANCER LETTERS (2012)
Cancer Stem Cells: Current Status and Evolving Complexities
Jane E. Visvader et al.
CELL STEM CELL (2012)
The rainbow trout liver cancer model: Response to environmental chemicals and studies on promotion and chemoprevention
David E. Williams
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
Sox2 expression in breast tumours and activation in breast cancer stem cells
O. Leis et al.
ONCOGENE (2012)
The Role of Cancer Stem Cells in Breast Cancer Initiation and Progression: Potential Cancer Stem Cell-Directed Therapies
Panagiota Economopoulou et al.
ONCOLOGIST (2012)
Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor
Emma Wincent et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links
Christina Scheel et al.
SEMINARS IN CANCER BIOLOGY (2012)
Expression of the pluripotency markers Oct3/4, Nanog and Sox2 in human breast cancer cell lines
Gui-Qin Ling et al.
ONCOLOGY LETTERS (2012)
NOTCH1 inhibition in vivo results in mammary tumor regression and reduced mammary tumorsphere-forming activity in vitro
Matthew J. Simmons et al.
BREAST CANCER RESEARCH (2012)
Development of Novel CH223191-Based Antagonists of the Aryl Hydrocarbon Receptor
Eun-Young Choi et al.
MOLECULAR PHARMACOLOGY (2012)
Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma
Claudia Lengerke et al.
BMC CANCER (2011)
Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients
Cristina Raimondi et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Estrogen and Cytochrome P450 1B1 Contribute to Both Early- and Late-Stage Head and Neck Carcinogenesis
Ekaterina G. Shatalova et al.
CANCER PREVENTION RESEARCH (2011)
Mechanisms of Chemical Carcinogenicity and Mutagenicity: A Review with Implications for Predictive Toxicology
Romualdo Benigni et al.
CHEMICAL REVIEWS (2011)
Malignant Transformation of Mammary Epithelial Cells by Ectopic Overexpression of the Aryl Hydrocarbon Receptor
J. Brooks et al.
CURRENT CANCER DRUG TARGETS (2011)
Environmental Exposures and Mammary Gland Development: State of the Science, Public Health Implications, and Research Recommendations
Ruthann A. Rudel et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
Tranilast treatment decreases cell growth, migration and inhibits colony formation of human breast cancer cells
Venkateswaran Subramaniam et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2011)
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Christiane A. Opitz et al.
NATURE (2011)
The cancer stem cell: premises, promises and challenges
Hans Clevers
NATURE MEDICINE (2011)
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Christine L. Chaffer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Neural Precursor Cell Proliferation Is Disrupted Through Activation of the Aryl Hydrocarbon Receptor by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin
Sarah E. Latchney et al.
STEM CELLS AND DEVELOPMENT (2011)
Aryl Hydrocarbon Receptor-Null Allele Mice Have Hematopoietic Stem/Progenitor Cells with Abnormal Characteristics and Functions
Kameshwar P. Singh et al.
STEM CELLS AND DEVELOPMENT (2011)
Coexpression of Oct4 and Nanog Enhances Malignancy in Lung Adenocarcinoma by Inducing Cancer Stem Cell-Like Properties and Epithelial-Mesenchymal Transdifferentiation
Shih-Hwa Chiou et al.
CANCER RESEARCH (2010)
Aldehyde Dehydrogenase 1-Positive Cancer Stem Cells Mediate Metastasis and Poor Clinical Outcome in Inflammatory Breast Cancer
Emmanuelle Charafe-Jauffret et al.
CLINICAL CANCER RESEARCH (2010)
Associations between Polycyclic Aromatic Hydrocarbon-Related Exposures and p53 Mutations in Breast Tumors
Irina Mordukhovich et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
Generalized Concentration Addition Predicts Joint Effects of Aryl Hydrocarbon Receptor Agonists with Partial Agonists and Competitive Antagonists
Gregory J. Howard et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2010)
Activation of the Aryl-Hydrocarbon Receptor Inhibits Invasive and Metastatic Features of Human Breast Cancer Cells and Promotes Breast Cancer Cell Differentiation
Julie M. Hall et al.
MOLECULAR ENDOCRINOLOGY (2010)
Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4
Melissa A. Barhoover et al.
MOLECULAR PHARMACOLOGY (2010)
Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist
Gerald J. Prud'homme et al.
PLOS ONE (2010)
Aryl Hydrocarbon Receptor Antagonists Promote the Expansion of Human Hematopoietic Stem Cells
Anthony E. Boitano et al.
SCIENCE (2010)
Epithelial-Mesenchymal Transition-Derived Cells Exhibit Multilineage Differentiation Potential Similar to Mesenchymal Stem Cells
Venkata Lokesh Battula et al.
STEM CELLS (2010)
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
Emmanuelle Charafe-Jauffret et al.
CANCER RESEARCH (2009)
The tryptophan photoproduct 6-formylindolo[3,2-b]carbazole (FICZ) binds multiple AHRs and induces multiple CYP1 genes via AHR2 in zebrafish
Maria E. Joensson et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Notch signalling in cancer stem cells
Victoria Bolos et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2009)
Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers
Tomonori Tanei et al.
CLINICAL CANCER RESEARCH (2009)
High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
Alysha K. Croker et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2009)
The pleiotropy of dioxin toxicity - Xenobiotic misappropriation of the aryl hydrocarbon receptor's alternative physiological roles
Sebastian G. B. Furness et al.
PHARMACOLOGY & THERAPEUTICS (2009)
Roles of Coactivator Proteins in Dioxin Induction of CYP1A1 and CYP1B1 in Human Breast Cancer Cells
Robert T. Taylor et al.
TOXICOLOGICAL SCIENCES (2009)
Cancer stem cells as targets for cancer therapy: selected cancers as examples
Sabine Hombach-Klonisch et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2008)
Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells
Hai-zhi Li et al.
BMC CANCER (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Constitutive regulation of CYP1B1 by the aryl hydrocarbon receptor (AhR) in pre-malignant and malignant mammary tissue
Xinhai Yang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Anne-Pierre Morel et al.
PLOS ONE (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
Christophe Ginestier et al.
CELL STEM CELL (2007)
Environmental pollutants and breast cancer -: Epidemiologic studies
Julia Green Brody et al.
CANCER (2007)
Sox2: a possible driver of the basal-like phenotype in sporadic breast cancer
Socorro M. Rodriguez-Pinilla et al.
MODERN PATHOLOGY (2007)
Requirement of aryl hydrocarbon receptor overexpression for CYP1B1 up-regulation and cell growth in human lung adenocarcinomas
Jinghua Tsai Chang et al.
CLINICAL CANCER RESEARCH (2007)
Trends for inflammatory breast cancer: Is survival improving?
Ana M. Gonzalez-Angulo et al.
ONCOLOGIST (2007)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor
Sun-Hee Kim et al.
MOLECULAR PHARMACOLOGY (2006)
Breast cancer stem cells: An overview
Dario Ponti et al.
EUROPEAN JOURNAL OF CANCER (2006)
A role for the aryl hydrocarbon receptor in mammary gland tumorigenesis
Jennifer J. Schlezinger et al.
BIOLOGICAL CHEMISTRY (2006)
Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma
UI Ezeh et al.
CANCER (2005)
Increased expression of MDM2, cyclin D1, and p27Kip1 in carcinogen- induced rat mammary tumors
SA Murray et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Survival of mammary stem cells in suspension culture: Implications for stem cell biology and neoplasia
G Dontu et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2005)
Oncogenic signaling pathways activated in DMBA-induced mouse mammary tumors
N Currier et al.
TOXICOLOGIC PATHOLOGY (2005)
The mammalian basic helix-loop-helix/PAS family of transcriptional regulators
RJ Kewley et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Bmi1, stem cells, and senescence regulation
IK Park et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Stem cells in normal breast development and breast cancer
G Dontu et al.
CELL PROLIFERATION (2003)
Aryl hydrocarbon receptor gene silencing with small inhibitory RNA differentially modulates Ah-responsiveness in MCF-7 and HepG2 cancer cells
M Abdelrahim et al.
MOLECULAR PHARMACOLOGY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The shared tumor-associated antigen cytochrome P4501B1 is recognized by specific cytotoxic T cells
B Maecker et al.
BLOOD (2003)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
The RelA NF-κB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells
DW Kim et al.
ONCOGENE (2000)
Transcriptional regulation of the human CYP1B1 gene -: Evidence for involvement of an aryl hydrocarbon receptor response element in constitutive expression
SE Shehin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Expression of the aryl hydrocarbon receptor/transcription factor (AhR) and AhR-regulated CYP1 gene transcripts in a rat model of mammary tumorigenesis
AF Trombino et al.
BREAST CANCER RESEARCH AND TREATMENT (2000)
分享论文
